Cargando…
Atypical CD5 and CD10 coexpression in a splenic marginal zone lymphoma
Autores principales: | Gimenez De Mestral, Santiago, Delhommeau, François, Fabiani, Bettina, Cervera, Pascale, Suner, Ludovic |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175870/ https://www.ncbi.nlm.nih.gov/pubmed/35845281 http://dx.doi.org/10.1002/jha2.155 |
Ejemplares similares
-
Clinico‐biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation
por: Bastidas‐Mora, Gabriela, et al.
Publicado: (2021) -
Splenic marginal zone lymphoma in Sweden 2000–2020: Increasing rituximab use and better survival in the elderly
por: Junlén, Henna‐Riikka, et al.
Publicado: (2023) -
CD79B and MYD88 Mutations in Splenic Marginal Zone Lymphoma
por: Trøen, Gunhild, et al.
Publicado: (2013) -
Marginal zone lymphoma expression of histidine‐rich glycoprotein correlates with improved survival
por: Persson Skare, Tor, et al.
Publicado: (2020) -
An unusual case of splenic B‐cell lymphoma/leukemia
por: Tashakori, Mehrnoosh, et al.
Publicado: (2021)